Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Capital Expenditures (2022 - 2025)

Historic Capital Expenditures for Lucid Diagnostics (LUCD) over the last 4 years, with Q3 2025 value amounting to $28000.0.

  • Lucid Diagnostics' Capital Expenditures changed N/A to $28000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $405000.0, marking a year-over-year increase of 9103.77%. This contributed to the annual value of $296000.0 for FY2024, which is 3393.67% up from last year.
  • Per Lucid Diagnostics' latest filing, its Capital Expenditures stood at $28000.0 for Q3 2025.
  • In the past 5 years, Lucid Diagnostics' Capital Expenditures ranged from a high of $2.1 million in Q2 2022 and a low of $14000.0 during Q3 2023
  • Moreover, its 4-year median value for Capital Expenditures was $65000.0 (2024), whereas its average is $321916.7.
  • As far as peak fluctuations go, Lucid Diagnostics' Capital Expenditures plummeted by 9926.9% in 2023, and later skyrocketed by 15135.14% in 2025.
  • Over the past 4 years, Lucid Diagnostics' Capital Expenditures (Quarter) stood at $1.0 million in 2022, then tumbled by 82.5% to $175000.0 in 2023, then surged by 48.0% to $259000.0 in 2024, then tumbled by 89.19% to $28000.0 in 2025.
  • Its Capital Expenditures was $28000.0 in Q3 2025, compared to $25000.0 in Q2 2025 and $93000.0 in Q1 2025.